Abstract:Obstructive sleep apnea hypoxia syndrome (OSAHS) is an independent risk factor for coronary artery disease (CAD). Treatment of OSAHS improves clinical outcome in some CAD patients, but the relationship between OSAHS and CAD is complex. Microparticles (MPs) are shed by the plasma membrane by either physiologic or pathologic stimulation. Here we investigated the role of MPs in the context of OSAHS. Patients with both suspected coronary artery stenosis and OSAHS were enrolled and underwent both coronary arteriography and polysomnography. 53 total patients in this study underwent cardiac angiography and PSG, and were divided into 3 groups per cardiac vessel stenosis extent and apnea/hypopnea index (AHI): 1) Control group, characterized by stenosis<50% and AHI<5; 2) CAD group: stenosis≥70% and AHI<5; 3) CAD+OSAHS group: stenosis≥70% and AHI>15. Circulating MPs were isolated from plasma and analyzed by flow cytometry. For permeability assay, FITC-CM-dextran was added in the upper channel after human aortic endothelial cells (HAECs) being stimulated with MPs in the transwell system. 53 patients were included in the present study, and there was no statistically significant demographic difference (age, sex, BMI, biological data, tobacco abuse, diabetes comorbidity) between the 3 groups. The AHI and 4% oxygen desaturation index (ODI) in the CAD+OSAHS group were significantly greater compared to both the control and CAD groups. Moreover, the mean SaO2 in the CAD+OSAHS group was decreased compared to the two other groups. CAD+OSAHS patients exhibited greater levels of total MPs (Annexin V+), erythrocyte-derived MPs (CD235+Annexin V+), platelet-derived MPs (CD41+ Anexin V+), and leukocyte-derived MPs (CD144+ Annexin V+) compared to CAD alone patients or control. CAD+OSAHS patients expressed the greatest level of endothelial-derived MPs of all cellular origin types (CD144+ Annexin V +). Treatment of human aortic endothelial cells (HAECs) with MPs isolated from CAD+OSAHS patients markedly increased HAEC permeability, and significantly upregulated mRNA levels of ICAM-1, VCAM-1, and MCP-1. OSAHS+CAD patients harbor increased levels of MPs, particularly the endothelial cell-derived subtype. When administered to HAECs, OSAHS+CAD patient MPs increase endothelial cell permeability and dysfunction. International Science & Technology Cooperation Program of China(2015DFA30160).

Circulating ESM-1 levels are correlated with the presence of coronary artery disease in patients with obstructive sleep apnea

Correlation between coronary artery disease and obstructive sleep apnea syndrome and analysis of risk factors

Relationship Between Endothelin-1 and Adrenomedullin in Patients with Obstructive Sleep Apnea-Hypopnea Syndrome

Diagnostic Role of Circulating Endocan Levels in Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis

Clinical significance of endothelial function markers detection in OSAHS patients combined with hypertension

Association of CLDN molecules with sleep apnea hypopnea syndrome: new biomarker candidates

1008 ENDOTHELIAL CELL-DERIVED MICROPARTICLES FROM OBSTRUCTIVE SLEEP APNEA HYPOXIA SYNDROME PATIENTS INCREASE HUMAN AORTIC ENDOTHELIAL CELL PERMEABILITY AND DYSFUNCTION

Effects of obstructive sleep apnea on inflammatory markers in patients with acute coronary syndrome

Biomarkers and Dynamic Cerebral Autoregulation of Obstructive Sleep Apnea-Hypopnea Syndrome

A Risk Biomarker for Obstructive Sleep Apnea in Patients with Coronary Artery Disease: Monocyte to High-Density Lipoprotein Ratio.

[The Role of Adhesion Molecules in the Pathogenic Mechanisms of Hypertension in Obstructive Sleep Apnea-Hypopnea Syndrome].

Study on the correlation between apolipoprotein E and gene polymorphism in coronary artery disease patients with obstructive sleep apnea

Obstructive sleep apnea is associated with coronary microvascular dysfunction: A systematic review from a clinical perspective

Research on Serum Amyloid A Protein Levels in Patients with Obstructive Sleep Apnea

Relationship between serum levels of endogenous secretory RAGE and blood pressure in male nondiabetic patients with obstructive sleep apnea

Circulating markers of oxidative stress and risk of incident cardiovascular events in obstructive sleep apnea

Association of C1q/TNF-Related Protein-9 (CTRP9) Level with Obstructive Sleep Apnea in Patients with Coronary Artery Disease

Serum Inflammatory Factors in Patients with Obstructive Sleep Apnea Syndrome and Coronary Heart Disease

The association between circulating APRIL levels and severity of obstructive sleep apnea in Chinese adults

Association between the circulating superoxide dismutase and obstructive sleep apnea: a meta-analysis

Clinical Utility of Biochemical Markers of Obstructive Sleep Apnea